These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 24261752)

  • 1. A proposal for management of rheumatic disease patients with hepatitis B virus infection receiving immunosuppressive therapy.
    Harigai M; Mochida S; Mimura T; Koike T; Miyasaka N
    Mod Rheumatol; 2014 Jan; 24(1):1-7. PubMed ID: 24261752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates on management strategies of hepatitis B virus reactivation in patients with resolved hepatitis virus B infection undergoing immunosuppressive therapy in rheumatology and the current situation in Niigata Rheumatic Center.
    Ito S
    Mod Rheumatol; 2021 Jul; 31(4):775-782. PubMed ID: 33021133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy.
    Lee YH; Bae SC; Song GG
    Clin Exp Rheumatol; 2013; 31(1):118-21. PubMed ID: 23111095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations.
    Mori S; Fujiyama S
    World J Gastroenterol; 2015 Sep; 21(36):10274-89. PubMed ID: 26420955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan.
    Fukuda W; Hanyu T; Katayama M; Mizuki S; Okada A; Miyata M; Handa Y; Hayashi M; Koyama Y; Arii K; Kitaori T; Hagiyama H; Urushidani Y; Yamasaki T; Ikeno Y; Suzuki T; Omoto A; Sugitani T; Morita S; Inokuma S
    Ann Rheum Dis; 2017 Jun; 76(6):1051-1056. PubMed ID: 27934678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving immunosuppressive therapy for glomerulonephritis: a retrospective analysis.
    Fang J; Li W; Peng X; Tan Z; Tan M; Zhang C; Wang W; Xu Z; Zhou G
    Int Urol Nephrol; 2017 Mar; 49(3):475-482. PubMed ID: 28032257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy.
    Stine JG; Khokhar OS; Charalambopoulos J; Shanmugam VK; Lewis JH
    Arthritis Care Res (Hoboken); 2010 May; 62(5):704-11. PubMed ID: 20461789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of hepatitis B virus reactivation after anti-tumour necrosis factor treatment in potential occult carriers with chronic inflammatory arthropathies.
    Biondo MI; Germano V; Pietrosanti M; Canzoni M; Marignani M; Stroffolini T; Salemi S; D'Amelio R
    Eur J Intern Med; 2014 Jun; 25(5):482-4. PubMed ID: 24495663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of anti-HBc-positive patients with rheumatic diseases treated with disease-modifying antirheumatic drugs-a single-center analysis of 2054 patients.
    Schwaneck EC; Krone M; Kreissl-Kemmer S; Weißbrich B; Weiss J; Tony HP; Gadeholt O; Schmalzing M; Geier A
    Clin Rheumatol; 2018 Nov; 37(11):2963-2970. PubMed ID: 30238380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
    Bonifati C; Lora V; Graceffa D; Nosotti L
    World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus reactivation by immunosuppressive therapy in patients with autoimmune diseases: risk analysis in Hepatitis B surface antigen-negative cases.
    Kato M; Atsumi T; Kurita T; Odani T; Fujieda Y; Otomo K; Horita T; Yasuda S; Koike T
    J Rheumatol; 2011 Oct; 38(10):2209-14. PubMed ID: 21844146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts.
    Tamori A; Koike T; Goto H; Wakitani S; Tada M; Morikawa H; Enomoto M; Inaba M; Nakatani T; Hino M; Kawada N
    J Gastroenterol; 2011 Apr; 46(4):556-64. PubMed ID: 21246383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis B virus infection in patients with rheumatic diseases in Tohoku area: a retrospective multicenter survey.
    Watanabe R; Ishii T; Kobayashi H; Asahina I; Takemori H; Izumiyama T; Oguchi Y; Urata Y; Nishimaki T; Chiba K; Komatsuda A; Chiba N; Miyata M; Takagi M; Kawamura O; Kanno T; Hirabayashi Y; Konta T; Ninomiya Y; Abe Y; Murata Y; Saito Y; Ohira H; Harigae H; Sasaki T
    Tohoku J Exp Med; 2014 Jun; 233(2):129-33. PubMed ID: 24898712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs.
    Lee YH; Bae SC; Song GG
    Int J Rheum Dis; 2013 Oct; 16(5):527-31. PubMed ID: 24164839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention.
    Mindikoglu AL; Regev A; Schiff ER
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1076-81. PubMed ID: 16861051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of hepatitis B reactivation with immunosuppressive therapy in rheumatic diseases. Orientations for clinical practice.
    Nunes J; Marinho RT; Fonseca JE; Pereira da Silva JA; Velosa J
    Acta Reumatol Port; 2011; 36(2):110-8. PubMed ID: 21841730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV reactivation in rheumatic diseases patients under therapy: A meta-analysis.
    Moghoofei M; Mostafaei S; Ashraf-Ganjouei A; Kavosi H; Mahmoudi M
    Microb Pathog; 2018 Jan; 114():436-443. PubMed ID: 29223453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection].
    Sato K
    Gan To Kagaku Ryoho; 2011 Feb; 38(2):161-8. PubMed ID: 21368477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis.
    Harigai M; Winthrop K; Takeuchi T; Hsieh TY; Chen YM; Smolen JS; Burmester G; Walls C; Wu WS; Dickson C; Liao R; Genovese MC
    RMD Open; 2020 Feb; 6(1):. PubMed ID: 32098857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.